Abstract The effect of eight vitamin E analogues (d-a-, dl-a-, d-b-, d-c-, and d-d-tocopherols, d-a-and dl-a-tocopheryl acetates) and 2,2,5,7,8-pentamethyl-6-hydroxychroman (PMC) on melanogenesis were compared in mouse B16 melanoma cells. D-btocopherol at 250 lg ml -1 inhibited not only 28% of melanin synthesis in B16 cells, but also 34% of the tyrosinase activity, a very important cascade enzyme involved in the synthesis of melanin in melanoma cells. D-c-tocopherol also strongly inhibited up to 39% of melanin synthesis and 45% of the tyrosinase enzyme activity at the same concentration. The inhibitory activity of both d-b-and d-c-tocopherols was observed without cytotoxicity up to a concentration of 250 lg ml -1 . Weak activity was also observed with d-d-tocopherol at 8 lg ml -1 and with PMC at 16 lg ml -1 , with 19% and 25% inhibition of melanin synthesis, respectively. However, PMC did not directly inhibit tyrosinase, as was observed with d-b-, d-c-, and d-d-tocopherols. Analysis by reverse transcription-polymerase chain reaction showed that the mechanism of melanogenesis inhibition by d-band d-c-tocopherols in cells might be attributed to reduced expression of tyrosinase and tyrosinase related protein-2 mRNA in addition to direct inhibition of the tyrosinase. These findings suggest that both d-b-tocopherol and d-c-tocopherol might be useful as effective ingredients in whitening cosmetics with lower skin toxicity to prevent or improve skin pigmentation such as skin spots and freckles caused by UV exposure.
Introduction
Recently women desiring skin whitening treatment have increased in Japan and the market for whitening cosmetics expands every year. Whitening cosmetics and ultraviolet absorption and dispersion cosmetics are used to protect their skin from pigmentation, blotches, and freckles caused by ultraviolet radiation. Natural product compounds are especially of interest as whitening cosmetics. Many contain plant extracts and a wide variety of the biomass is believed to be an attractive bioresource to screen for inhibitors of melanin synthesis Cho et al. 2006; Hermanns et al. 2002; Hwang and Lee 2007; Kim et al. 2002; Lee et al. 2003; Lin et al. 2007; Tanimoto et al. 2006; Thongchai et al. 2007; Wang et al. 2006) .
In this background, we also searched for new biological compounds in natural products and screened for inhibitors of melanin synthesis in over 300 species of marine algae from the Japanese coastlines. We found that b-carotene from several species of marine algae is an active antimelanogenic compound (Kamei 2001) . Since b-carotene has antioxidant activity, other antioxidant compounds like vitamin E analogues may also inhibit melanin synthesis. Indeed, one of the vitamin E analogues, a-tocopherol has been reported to have antimelanogenic activity (Funasaka et al. 1999; Funasaka et al. 2000; Hachinohe and Matsumoto 2005; Yamamura et al. 2002) . Melanin biosynthesis is regulated by tyrosinase which is a key enzyme in melanogenesis in melanocytes (Körner and Pawelek 1982) and other enzymes in the tyrosinase-family such as tyrosinase related protein (TRP)-1 and TRP-2 (Jackson et al. 1992; Jimènez-Cervantes et al. 1994; Kobayashi et al. 1994; Tsukamoto et al. 1992 ). However, Funasaka et al. (1999) reported that atocopherol not only directly inactivates tyrosinase, but may also affect the post-translation levels of tyrosinase, TRP-1 and TRP-2. Thus since a-tocopherol has antimelanogenic activity, other vitamin E analogues may also suppress melanogenesis in pigment cells by directly inhibiting the enzymes or the translation of mRNAs for tyrosinase-family enzymes.
In this study, we used mouse B16 melanoma cells to evaluate the antimelanogenic activity of vitamin E because B16 cells have been known as a model melanoma cell line to evaluate such an biological activity (Kamaraju et al. 2004) . Eight vitamin E analogues, and 2, 2, 5, 7, were evaluated for antimelanogenic activity to mouse B16 melanoma cells which might possibly be developed as vitamin E analogues for skin whitening cosmetics. In addition, the mechanism of melanogenesis inhibition by active vitamin E compounds was analyzed. and cultured under the same conditions described above. The cells were harvested by centrifugation, then the color of the cell pellets were evaluated visually after being cultured in the presence of vitamin E analogues for 3 days.
Materials and methods

Experimental reagents
Antimelanogenesis assay B16 melanoma cells were plated at 2.4 9 10 4 cells 300 ll -1 well -1 in a 48-well plate and cultured in DMEM for 24 h. After incubation, the medium was refreshed with medium containing one of eight vitamin E analogues serially diluted 1/2 to concentrations ranging from 3.9 to 500 lg ml -1 and the cells incubated for another 3 days. After incubation, the cells were washed with phosphate-buffered saline (PBS) and completely lysed by sonication and dissolved in 100 ll of 2 M NaOH. The melanin content in the cell lysates was estimated by use of a standard curve made with synthetic melanin. The absorbance at 405 nm was measured in a microplate reader (Model 450, Bio-Rad). The inhibition of melanin synthesis was evaluated by comparing samples with a negative control that did not contain a vitamin E analogue.
Cytotoxicity test
The cytotoxicity of vitamin E analogues in B16 cells was tested in vitro by MTT assay (Mosmann 1983) . The B16 cells were seeded into a 48-well plate and cultured in the presence of vitamin E samples as described above. After a 3-day incubation, 30 ll of 5 mg ml -1 3-[4,5-dimethylthiazol-2-ly]-2,5-diphenyltetrazolium bromide (MTT) was added to 300 ll of cell culture in the plates. After dissolving the cells in 300 ll of 10% SDS in 0.01 M HCl, the cells were incubated at 37°C for 4 h and the absorbance at 570-655 nm was measured in a microplate reader. The growth rate as an index of cytotoxicity was calculated by dividing the test cell number by the numbers of cells in the corresponding control sample.
Tyrosinase inhibition assay
Tyrosinase activity was determined by colorimetric assay of 3,4-dihydroxyphenylalanine (DOPA) oxidase activity. B16 cells (2.0 9 10 3 cells 100 -1 ll well -1 ) were plated into 96-well microplates and cultured in DMEM containing 0.5 mM theophylline for 2 days. The culture medium was refreshed with medium containing one of vitamin E analogues as describe above and cultured for another 3 days. The medium was removed and the cells were washed with PBS. The cells were lysed with 100 ll of 1% triton X-100 in PBS. The reaction was initiated by addition of 10 ll of 10 mM L-DOPA. The absorbance was measured at 490 nm immediately after adding the L-DOPA. The plate was incubated at 37°C for 1 h and the absorbance at 490 nm was measured. The inhibition of tyrosinase inhibiting activities by the vitamin E analogues was evaluated by comparing them with the activity of a negative control containing no analogues.
RT-PCR assay
Total RNA was extracted from 1 9 10 6 cells ml
B16 cells cultured in the presence of 62.5,125, and 250 lg ml -1 of each vitamin E analogue in a 100 mm-dish for 3 days. The total RNA was reverse transcribed at 42°C for 60 min in the presence of oligo(dT) 20 primers (Toyobo) and reverse transcriptase (ReverTra Ace, Toyobo). cDNA was amplified by the polymerase chain reaction (PCR) at 94°C for 5 min by 1 cycle, 98°C for 20 s, 68°C for 7 min followed by a 10 min elongation cycle at 72°C using a GeneAmp PCR System 2400 (ABI). The oligonucleotides primers for mouse tyrosinase (forward, 5 0 -TGGCCAAATGAACAATGGGTCAAC-3 0 ; reverse, 5 0 -GGTCCCTCAGGTGTTCCA-TCGCAT-3 0 ), mouse TRP-2 (forward, 5 0 -GATGTT-AGAGGAGCT TCGGATG-3 0 ; reverse, 5 0 -GAAGGATATAAGGGC CACTCC-3 0 ), and mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control (forward, 5 0 -GGTGAAGGTCGGTGTGAACG-3 0 ; reverse, 5 0 -CTT-GGAGGCCATGTAGGCCATG-3 0 ) were used. The PCR products from the PCR amplification of tyrosinase and TRP-2 mRNA was electrophoresed at 100 V for 40 min on a 2% agarose gel in TAE buffer (40 mM Tris-acetate, 2 mM EDTA, pH 8.0) containing 0.5 lg ml -1 ethidium bromide. After electrophoresis, the signal intensity of each band was quantified with NIH-Image Software Ver. 1.62 and decrease in expression of tyrosinase and TRP-2 mRNA by vitamin E analogues was evaluated relative to the internal control PCR product.
Results
Depigmentation of B16 cell pellets
The eight vitamin E analogues (d-a-, dl-a-, d-b-, and d-d-tocopherols, d-a-and dl-a-tocopheryl acetates, and PMC) used in this study are shown in Fig. 1 . These vitamin E analogues as well as d-a-tocopherol which was from a different lot number from that of another d-a-tocopherol were tested for their ability to depigment B16 cells by direct observation of the cell pellets after treatment. A reduction in melanogenesis in B16 cells compared with a negative control was observed in cells treated with four of the tested analogues, d-b-, d-c-, and d-d-tocopherols, and PMC. However, d-d-tocopherol and PMC also reduced the amount of cells, probably due to cytotoxicity (Fig. 2) .
Melanogenesis inhibition in B16 cells
Four vitamin E analogues, d-b-, d-c-, and d-dtocopherols, and PMC also exhibited intracellular Cytotechnology (2009) 59:183-190 185 antimelanogenic activity in B16 cells when the melanin content was measured directly based on a standard curve made using synthetic melanin (Fig. 3) . However, antimelanogenic activity was not found with d-a-tocopherol in this experiment although atocopherol has been reported to have antimelanogenic activity. D-d-tocopherol and PMC, both had cytotoxic effects on B16 cells at higher concentrations of over 16 lg ml -1 . The antimelanogenic activity of both db-and d-c-tocopherols were dose dependant. (Fig. 3) , these 4 vitamin E analogues were tested to see if they directly inactivated tyrosinase in B16 cells. These tocopherols exhibited inhibitory activity against intracellular tyrosinase that was similar to the intracellular antimelanogenesis observed. The most potent inactivation of tyrosinase was found with d-d-tocopherol at lower concentrations of below 31 lg ml -1 , with over 90% inhibition of tyrosinase activity (Fig. 4) . PMC was also a potent inhibitor at over 125 lg ml -1 . However, although both d-b-tocopherol and d-c-tocopherol had lower activity compared with d-d-tocopherol and PMC, both still had relatively high tyrosinase-inhibiting activity of over 30% at 63 lg ml -1 . At these concentrations, no cytotoxicity by d-b-tocopherol and d-c-tocopherol was observed as shown in Fig. 3 .
d-α-tocopherol d-δ-tocopherol
Inhibition of tyrosinase and TRP-2 mRNA levels by d-b-tocopherol and d-c-tocopherol
Before attempting to elucidate the mechanisms of antimelanogenesis of B16 cells by active vitamin E analogues in B16 cells by RT-PCR analysis of tyrosinase and TRP-2 mRNA levels, we first determined the quantity of total RNA for RT-PCR. At concentrations ranging from 0.08 to 10 ng ll -1 of total RNA, the quantity of both tyrosinase and TRP-2 mRNA were observed at concentrations ranging from 0.63 ng ll -1 to 2.5 ng ll -1 (data not shown). From these results, therefore, 1.3 ng ll -1 total RNA was chosen for use in RT-PCR to determine tyrosinase and TRP-2 mRNA levels. Under these conditions, db-tocopherol reduced tyrosinase and TRP-2 mRNA expression levels in a dose dependant manner at concentrations of 62.5 lg ml -1 to 250 lg ml -1 (Fig. 5) . D-c-tocopherol also reduced the mRNA levels of both enzymes in a dose dependant manner at the same concentrations (Fig. 6 ). In particular, these compounds reduced the expression of mRNAs for these enzymes beyond a concentration of 125 lg ml -1 of d-c-tocopherol. These results indicate that d-c-tocopherol also suppresses the mRNA levels of tyrosinase and TRP-2 in B16 cells.
Discussion
In a large screening programs of biologically active compounds from marine algae, we showed that the well-known antioxidant b-carotene has potent antimelanogenic activity in mouse B16 melanoma cells, after purifying and determining it to be the active compound in the extracts from an antimelanogenesis-positive marine algae using activity-guided purification techniques (Kamei 2001) . Based on our previous result, we hypothesized that another wellknown antioxidant, vitamin E also might potentially have antimelanogenic activity. In this study, we determined the antimelanogenic activity of vitamin E analogues in B16 cells that might potentially be developed as ingredients in skin whitening cosmetics. Four of 8 vitamin E analogues tested had antimelanogenic activity in B16 cells. In particular, d-b-tocopherol and d-c-tocopherol showed promising antimelanogenic activity with less cytotoxicity at relatively high concentrations of up to 250 lg ml -1 . However, no strong antimelanogenic activity was observed with d-a-tocopherol or dl-atocopherol in this study although antimelanogenic activity of d-a-tocopherol alone (Yamamura et al. 2002) or in the presence of ferulic acid (Funasaka et al. 1999; Funasaka et al. 2000) has been reported. This might be attributed to the number of methyl residues bound to benzene ring of these tocopherols. aTocopherol has three methyl residues bound to its benzene ring, however, d-b-tocopherol and d-ctocopherol have two methyl residues bound to the benzene ring in their structure. This property may 
, and a-tocopherol is worst among them (Wu et al. 2000) . This biological property might be attributed to the number of methyl residues bound to the benzene ring of a-tocopherol which has three methyl residues on the benzene ring of this structure. Such structural difference may cause antimelanogenic activity in B16 cells. Furthermore the difference in antimelanogenic activity with d-atocopherol in the previous report and in our present results might be due to the different property between synthesized and natural a-tocopherol products. We used the natural product of a-tocopherol extracted from soybean oil in this study. Antimelanogenic activity is also not likely based on the different optical forms (dand dl-forms) of a-tocopherol isomers.
When we evaluated the mechanisms of antimelanogenic activity of d-b-tocopherol and d-c-tocopherol in B16 cells, both tocopherols strongly inhibited intracellular tyrosinase activity. Furthermore, both tocopherols also suppressed the mRNA expression of tyrosinase and TRP-2. D-b-tocopherol and d-ctocopherol might specifically inhibit the production of tyrosinase and TRP-2 in B16 cells. From these results, the mechanism of antimelanogenic activity of d-b-tocopherol and d-c-tocopherol appeared to be two-fold; direct inactivation of the tyrosinase enzyme and suppression of the mRNA expression of both tyrosinase and TRP-2. Since tyrosinase is a key enzyme in the melanin synthetic pathway in melanocytes, the strong inhibitory effects of d-b-tocopherol and d-c-tocopherol directly against the tyroninase enzyme are likely to be very important in the suppression of melanogenesis in these cells. Such a direct inactivation of tyrosinase by vitamin E has been reported previously (Funasaka et al. 1999) . In our study, we found potent inhibitory effects by dd-tocopherol and PMC on tyrosinase, however, these compounds were also cytotoxic at the same concentrations required to inhibit melanin synthesis which would prohibit their inclusion into skin care products like skin whitening cosmetics. This is the first report showing tyrosinase enzyme inhibition by vitamin E analogues like d-b-tocopherol and d-c-tocopherol. The results suggest that d-btocopherol and d-c-tocopherol might be effective and suitable antimelanogenic components for use in whitening cosmetics to prevent or improve the undesirable skin pigmentation such as skin spots and freckles caused by UV exposure.
